Language selection

Government of Canada / Gouvernement du Canada

Search

Guidance on nitrosamine impurities in medications.: H164-327/2023E-2-PDF

"Evaluating and managing the risks of N-nitrosamine impurities in human pharmaceutical, biological and radiopharmaceutical products"--Cover.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.928221&sl=0

Publication information
Department/Agency
  • Canada. Health Canada, issuing body.
TitleGuidance on nitrosamine impurities in medications.
Publication typeMonograph
Language[English]
Other language editions[French]
Later editionGuidance on nitrosamine impurities in medications. (March 2024)
Earlier editionGuidance on nitrosamine impurities in medications. (July 2023)
FormatDigital text
Electronic document
Note(s)
  • Cover title.
  • "Date Adopted: October 20, 2023. Effective Date: October 20, 2023."
  • Issued also in French under title: Lignes directrices sur les impuretés de nitrosamine dans les médicaments.
  • Includes bibliographical references.
Publishing information
  • Ottawa, ON : Health Canada = Santé Canada, 2023.
  • ©2023
Description1 online resource (iii, 64 pages) : illustrations
ISBN9780660682013
Catalogue number
  • H164-327/2023E-2-PDF
Departmental catalogue number230473
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: